• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Bacterial Infections  • Infectious Diseases, Other  • Pneumonia  • Quality of Care  • Quality of Care, Other  • Prognosis/ Outcomes  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Community-Acquired Pneumonia Organization International Cohort Study Results

Forest W. Arnold, DO; A. Scott LaJoie, PhD; Guy N. Brock, PhD; Paula Peyrani, MD; Jordi Rello, MD; Rosario Menéndez, MD; Gustavo Lopardo, MD; Antoni Torres, MD; Paolo Rossi, MD; Julio A. Ramirez, MD; for the Community-Acquired Pneumonia Organization (CAPO) Investigators

Arch Intern Med. 2009;169(16):1515-1524.

Background  To define whether elderly patients hospitalized with community-acquired pneumonia (CAP) had better outcomes if they were treated with empirical antimicrobial therapy adherent to the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) guidelines for CAP.

Methods  This was a secondary analysis of the CAPO International Cohort Study database, which contained data from a total of 1725 patients aged 65 years or older who were hospitalized with CAP. Data from June 1, 2001, until January 1, 2007, were analyzed from 43 centers in 12 countries including North America (n = 2), South America (n = 4), Europe (n = 4), Africa (n = 1), and Southeast Asia (n = 1). Initial empirical therapy for CAP was evaluated for guideline compliance according to the 2007 IDSA/ATS guidelines for CAP. Time to clinical stability, length of stay (LOS), total in-hospital mortality, and CAP-related mortality for each group were calculated. Comparisons between groups were made using cumulative incidence curves and competing risks regression.

Results  Among the 1649 patients with CAP, aged 65 years or older, 975 patients were given antimicrobial regimens adherent to the IDSA/ATS for CAP guidelines, while 660 patients were treated with nonadherent regimens (465 patients were "undertreated"; 195 were "overtreated"). Adherence to guidelines was associated with a statistically significant decreased time to achieve clinical stability compared with nonadherence: the proportion of patients who reached clinical stability by 7 days was 71% (95% confidence interval [CI], 68%-74%) and 57% (95% CI, 53%-61%) (P < .01), respectively. Guideline adherence was also associated with shorter LOS (median adherence LOS, 8 days; interquartile range [IQR], 5-15 days; median nonadherence LOS, 10 days; IQR, 6-24 days) (P < .01) and decreased overall in-hospital mortality (8%; 95% CI, 7%-10% vs 17%; 95% CI, 14%-20%) (P < .01).

Conclusion  Implementation of national guidelines at the local hospital level will improve not only mortality and LOS of elderly patients hospitalized with CAP but also time to clinical stability.

Author Affiliations: Division of Infectious Diseases, University of Louisville School of Medicine (Drs Arnold, Peyrani, and Ramirez), and Departments of Health Promotion and Behavioral Sciences (Dr LaJoie) and Bioinformatics and Biostatistics (Dr Brock), University of Louisville, Louisville, Kentucky; Critical Care Department, Joan XXIII University Hospital–Ciber de Enfermedades Respiratorias (CIBER), University Rovira & Virgili–IISPV, Tarragona, Spain (Dr Rello); Pneumology Service, Hospital Universitario La Fe, CIBER, Valencia, Spain (Dr Menéndez); Department of Infectious Diseases, Hospital Profesor Bernardo Houssay, Buenos Aires, Argentina (Dr Lopardo); Pneumology Department of the Hospital Clinic, CIBER, Institut d’Investigacions Biomédiques August Pi I Sunyer, Barcelona, Spain (Dr Torres); and Division of Internal Medicine, Department of Medicine, Azienda Ospedaliero–Universitaria di Udine, Udine, Italy (Dr Rossi).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Guideline-Recommended Antibiotics in Community-Acquired Pneumonia: Not Perfect, but Good
Bradley A. Sharpe
Arch Intern Med. 2009;169(16):1462-1464.
EXTRACT | FULL TEXT  

Guideline-Concordant Therapy and Reduced Mortality and Length of Stay in Adults With Community-Acquired Pneumonia: Playing by the Rules
Caitlin McCabe, Cheryl Kirchner, Huiling Zhang, Jennifer Daley, and David N. Fisman
Arch Intern Med. 2009;169(16):1525-1531.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Initial management of pneumonia and sepsis: factors associated with improved outcome
Menendez et al.
Eur Respir J 2012;39:156-162.
ABSTRACT | FULL TEXT  

Divergent Intentions to Use Antibiotic Guidelines: A Theory of Planned Behavior Survey
Cortoos et al.
Med Decis Making 2012;32:145-153.
ABSTRACT | FULL TEXT  

Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation
Cortoos et al.
J Antimicrob Chemother 2011;66:2864-2871.
ABSTRACT | FULL TEXT  

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
Grenier et al.
J Antimicrob Chemother 2011;66:1617-1624.
ABSTRACT | FULL TEXT  

An Appraisal of the Evidence Underlying Performance Measures for Community-acquired Pneumonia
Wilson and Schunemann
Am. J. Respir. Crit. Care Med. 2011;183:1454-1462.
ABSTRACT | FULL TEXT  

A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments
McIntosh et al.
Int J Qual Health Care 2011;23:142-150.
ABSTRACT | FULL TEXT  

Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
Khan et al.
Clinical Infectious Diseases 2010;51:1147-1156.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines Can Improve Quality of Care and Reduce Costs
Rifkin and Askren-Gonzalez
Arch Intern Med 2010;170:1173-1173.
FULL TEXT  

Update in Community-acquired and Nosocomial Pneumonia 2009
Torres and Rello
Am. J. Respir. Crit. Care Med. 2010;181:782-787.
FULL TEXT  

Antibiotic Guideline Compliance and Outcomes for CAP
JWatch Emergency Med. 2009;2009:2-2.
FULL TEXT  

CAP Treatment Recommendations: Guided in the Right Direction
JWatch Infect. Diseases 2009;2009:2-2.
FULL TEXT  

All you need to read in the other general journals
BMJ 2009;339:b3877-b3877.
FULL TEXT  

Guideline-Recommended Antibiotics in Community-Acquired Pneumonia: Not Perfect, but Good
Sharpe
Arch Intern Med 2009;169:1462-1464.
FULL TEXT